Raymond M Jordt Altimmune, Inc. (ALT) insider trading activity

Raymond M Jordt is Chief Business Officer of Altimmune, Inc.. Currently has a direct ownership of 43,170 shares of ALT, which is worth approximately $180,018. The most recent transaction as insider was on Jan 01, 2026, when has been sold 2,475 shares (Common Stock, par value $0.0001) at a price of $3.61 per share, resulting in proceeds of $8,934. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.2K

19.02% 3M change

100.32% 12M change

Total Value Held $180,018

Raymond M Jordt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2026	SELL Payment of exercise price or tax liability	$8,934 $3.61 p/Share	2,475 Reduced 5.42%	43,170 Common Stock, par valu...
Jan 01 2026	BUY Exercise of conversion of derivative security	-	9,375 Added 17.04%	45,645 Common Stock, par valu...
Jul 31 2025	BUY Grant, award, or other acquisition	$4,295 $3.14 p/Share	1,368 Added 3.63%	36,270 Common Stock, par valu...
Jan 31 2025	BUY Grant, award, or other acquisition	$13,540 $5.18 p/Share	2,614 Added 6.97%	34,902 Common Stock, par valu...
Jan 25 2025	SELL Payment of exercise price or tax liability	$26,956 $6.98 p/Share	3,862 Reduced 10.68%	32,288 Common Stock, par valu...
Jan 25 2025	BUY Exercise of conversion of derivative security	-	14,600 Added 28.77%	36,150 Common Stock, par valu...
Jan 01 2025	SELL Payment of exercise price or tax liability	$17,916 $7.21 p/Share	2,485 Reduced 10.34%	21,550 Common Stock, par valu...

Jan 01 2025	BUY Exercise of conversion of derivative security	-	9,375 Added 28.06%	24,035 Common Stock, par valu...
Jul 31 2024	BUY Grant, award, or other acquisition	$4,960 $5.41 p/Share	917 Added 5.89%	14,660 Common Stock, par valu...
Jan 31 2024	BUY Grant, award, or other acquisition	$13,530 $2.69 p/Share	5,030 Added 26.79%	13,743 Common Stock, par valu...
Jan 01 2024	SELL Payment of exercise price or tax liability	$28,158 $11.25 p/Share	2,503 Reduced 22.33%	8,704 Common Stock, par valu...
Jan 01 2024	BUY Exercise of conversion of derivative security	-	9,375 Added 45.55%	11,207 Common Stock, par valu...
Jul 31 2023	BUY Grant, award, or other acquisition	$5,147 $2.81 p/Share	1,832 Added 50.0%	1,832 Common Stock, par valu...

RMJ

Raymond M Jordt

Chief Business Officer

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALT shares.

Notify only if

Value

Insider Trading

Get notified when an Altimmune, Inc. insider buys or sells ALT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Altimmune, Inc.

Track Activities on ALT

Account